Benzinga | Sep 28, 2020 04:02PM EDT

Altimmune To Present Highlights Of Intranasal COVID-19 Vaccine And Therapeutic Programs AdCOVID And T-COVID At World Vaccine Congress Sept. 21-Oct. 1

GAITHERSBURG, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a clinical-stage biopharmaceutical company, today announced that Scot Roberts, Ph.D., Chief Scientific Officer of Altimmune, Inc., presented an overview of the Company's AdCOVID and T-COVID intranasal vaccine and therapeutic candidates during a special COVID-19 virtual session of the World Vaccine Congress Washington, taking place September 28 -- October 1, 2020.



A link to Dr. Roberts' presentation is available on Altimmune's website at www.altimmune.com. The presentation can be accessed under the 'Investors' section of the website under 'Events and Presentations.'

The World Vaccine Congress Washington 2020 brings together global leaders from industry, academia and public health to advance the development of vaccine technologies. This year's conference features a special COVID-19 segment dedicated to expanding knowledge to facilitate the rapid development of vaccines to address the global COVID-19 pandemic.